Besides its demonstrated association with carcinoma prognosis, ITPKA promotes cancer cell growth, invasion, and migration in renal cell carcinoma (Zhu et al., 2020) and lung adenocarcinoma (Guoren et al., 2020). Here, ITPKA is linked to renal cell carcinoma.